Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 Next >
Rosetta Genomics Launches miRview Kidney
May 15, 2012
New microRNA-Based Diagnostic Test for Classification of Four Common Kidney Tumor Types Now Available Read More
from Marketwired News Releases
Rosetta Genomics Announces One-for-Fifteen Reverse Stock Split
May 14, 2012
Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on May 15, 2012 Read More
from Marketwired News Releases
Rosetta Genomics Receives Key U.S. Patent Allowance
April 23, 2012
Composition of Matter Patent Covers Core Component of Company's Lead Diagnostics for Cancer of Unknown and Uncertain Primary Read More
from Marketwired News Releases
FUEL, ROSG and ONTC are the Stocks to Watch for April 20th from OTCPicks.com
April 20, 2012
from EmailWire.Com Press Releases
Rosetta Genomics Receives Key European Patent in Oncology
April 19, 2012
Patent Awarded for the Use of miR-34a for the Preparation of Pharmaceuticals for Treating p53-Negative Cancers Read More
from Marketwired News Releases
Rosetta Genomics to Raise $1.38 Million in Registered Direct Offering
April 12, 2012
from Marketwired News Releases
BMTL, RCON, GALE and ROSG are the Stocks to Watch for March 21st from OTCPicks.com
March 21, 2012
from EmailWire.Com Press Releases
Study Published in International Journal of Oncology Shows Potential for microRNAs to Determine Risk of Recurrence in Colorectal Cancer
March 20, 2012
from Marketwired News Releases
ROSG and RCON are the Daily Market Movers for March 20th from OTCPicks.com
March 20, 2012
from EmailWire.Com Press Releases
Rosetta Genomics to Present Multiple Poster Presentations at the 101st Annual Meeting of the United States and Canadian Academy of Pathology
March 19, 2012
miRview mets2 Demonstrates 92% Concordance With Clinical and Pathological Testing in Cancer of Unknown Primary Read More
from Marketwired News Releases
Rosetta Announces $1.75 Million Debt Financing and Potential $1.25 Million Licensing Transaction
January 27, 2012
from Marketwired News Releases
Rosetta Genomics Sells Ownership in Rosetta Green
December 19, 2011
from Marketwired News Releases
Rosetta Genomics Announces New York State Approval for miRview mets²
December 09, 2011
Proprietary microRNA Diagnostic for Identification of Cancer of Unknown Primary Now Available in All 50 U.S. States Read More
from Marketwired News Releases
GZGT, ROSG, WNYN, IMDS and PEIX are the Daily Market Movers for December 2nd from OTCPicks.com
December 02, 2011
from EmailWire.Com Press Releases
Study Showing Potential for microRNAs as Biomarkers for Heart Failure Prognosis Published in European Journal of Heart Failure
November 28, 2011
from Marketwired News Releases
Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence
November 04, 2011
from PR Newswire
Rosetta Genomics Initiates Closing of Private Placement
October 19, 2011
from PR Newswire
Rosetta Genomics to Raise $1.9 Million in Private Placement
October 13, 2011
from PR Newswire
Rosetta Genomics Restructures to Reduce Operating Expenses and Focus on Commercial Opportunities
October 11, 2011
from PR Newswire
Rosetta Genomics Announces Exclusive License with Avatao Biotech for Distribution of miRview Tests in China
October 11, 2011
Avatao is Supported by Kunshan microRNA Institute Read More
from PR Newswire
Rosetta Genomics to Present at Rodman & Renshaw 13th Annual Global Investment Conference
September 08, 2011
Webcast Scheduled for September 13, 2011 at 11:40 a.m. Eastern Time Read More
from PR Newswire
Rosetta Green Joins the Seventh EC Framework Program: Receives 0.5 Million Euro Grant to Develop Proteins and Chemicals in Algae for Therapeutic and Industrial Products
July 27, 2011
from GlobeNewswire News Releases
Rosetta Genomics Reports Preliminary Data on Discovery of Blood-Based microRNA Signature for Identification and Stratification of Heart Failure Patients
July 26, 2011
from Marketwired News Releases
Rosetta Genomics Regains Compliance With NASDAQ Minimum Bid Price Rule
July 21, 2011
from Marketwired News Releases
Rosetta Genomics Announces One-For-Four Reverse Stock Split
July 06, 2011
Ordinary Shares Will Begin Trading on a Split-Adjusted Basis on July 7, 2011 Read More
from PR Newswire
Rosetta Genomics and UC Davis Researchers to Develop and Validate microRNA Biomarker to Predict Response to Neoadjuvant Chemotherapy in Bladder Cancer
June 28, 2011
from PR Newswire
Data Demonstrating the Ability of miRview mets(2) to Identify Tissue of Origin in Cancer of Unknown Primary Presented at ASCO 2011
June 16, 2011
Post-Marketing Validation Study With Second-Generation Test Demonstrates 88% Concordance With Clinical Presentation and Pathology; Ability to Test Decalcified Bone Specimens on the miRview mets(2)... Read More
from Marketwired News Releases
Rosetta Genomics Signs Marketing Agreement With PACE Claims Services for miRview(R) meso
June 14, 2011
Market Leader in Asbestos Claims Administration to Highlight the Value of Accurate Mesothelioma Diagnostics With Defendants and Insurers Read More
from Marketwired News Releases
Rosetta Genomics Reports First Quarter 2011 Financial Results
June 01, 2011
from Marketwired News Releases
Rosetta Genomics and Collaborators to Present Data at ASCO 2011
May 23, 2011
Multiple Presentations Demonstrate the Clinical Utility of miRview Products in Identifying and Classifying Various Cancers Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here